Case Reports in Endocrinology , 2024, Article ID 678910
Lipid-Lowering Therapies Traditional lipid-lowering therapies statins, ezetimibe, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, inclisiran, and bempedoic acid primarily reduce circulating apolipoprotein B (ApoB)containing lipoproteins, which both retards new atherogenesis and, at sufficient magnitude, drives angiographic plaque regression [15][17]
You won't walk out with a pamphlet and a follow-up in three months that's not how I practice
they offer comprehensive improvements in metabolic health, contributing to enhanced overall well-being and reduced risk of diabetes and heart disease
Although some studies of SARS-CoV in animal models do not show evidence of ADE or ERD 33,42,43 , safety should be considered when designing vaccines for SARS-CoV-2